-
Product Insights
NewT-Cell Leukemia – Drugs In Development, 2024
Empower your strategies with our T-Cell Leukemia – Drugs In Development, 2024 report and make more profitable business decisions. T-cell leukemia is a rare type of blood cancer that affects T cells, which are white blood cells that help your body fight infection or illness. There are different types of T-cell leukemia, such as large granular lymphocytic leukemia, adult T-cell leukemia/lymphoma, and T-cell prolymphocytic leukemia. These types vary in their symptoms, risk factors, diagnosis, treatment and outlook. T-cell leukemia can be...
-
Product Insights
NewGastrointestinal Tumor – Drugs In Development, 2024
Empower your strategies with our Gastrointestinal Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Gastrointestinal (GI) tumors refer to abnormal growths or neoplasms that develop in various parts of the digestive system, which includes the esophagus, stomach, intestines (small and large), liver, gallbladder, and pancreas. These tumors can be benign (non-cancerous) or malignant (cancerous). The Gastrointestinal Tumor drugs in development market research report provide comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with...
-
Product Insights
NewPeripheral T-Cell Lymphomas (PTCL) – Drugs In Development, 2024
Empower your strategies with our Peripheral T-Cell Lymphomas (PTCL) – Drugs In Development, 2024 report and make more profitable business decisions. Peripheral T-cell lymphomas (PTCL) constitute a diverse group of rare and aggressive non-Hodgkin lymphomas originating from mature T cells. These malignancies involve lymphoid tissues and may affect organs throughout the body. PTCLs are heterogeneous, comprising various subtypes with distinct clinical behaviors and outcomes. Symptoms may include enlarged lymph nodes, fever, weight loss, and night sweats. Diagnosis involves biopsies, imaging studies,...
-
Product Insights
Acute Myelocytic Leukemia (AML) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
AML Pipeline Products Market Report Overview Acute myelocytic leukemia (AML), also known as acute myelogenous leukemia is a type of cancer that affects the blood and the bone marrow. Immature white blood cells accumulate in the bone marrow thus blocking the production of normal blood cells. These cells further enter the bloodstream and spread to the other parts of the body. Symptoms of AML include fatigue, fever, bleeding, breathing problems, and weight loss. The predisposing factors involved are exposed to...
-
Product Insights
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Symptoms may include night sweats, fever and chills that come and go, itching, putting pressure on the windpipe (trachea) or other airways, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if cancer affects the brain. Treatment includes surgery,...
-
Product Insights
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastric Cancer signs and symptoms include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Treatment includes surgery, chemotherapy, and radiation therapy. The Gastric Cancer pipeline drugs market research report provides an analysis of the Gastric Cancer drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and...